Biotech Stock Roundup: GILD, BMY's Regulatory News, BLUE's Therapy Approval & More

This article was originally published on Nasdaq

It has been a busy week for the biotech companies with a plethora of important updates. Drug approvals and other regulatory news grabbed the spotlight this week.

Responses